Arlington Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.73M |
| 2 |
Constellation Brands
STZ
|
+$2.57M |
| 3 |
Live Nation Entertainment
LYV
|
+$2.36M |
| 4 |
Haleon
HLN
|
+$2.35M |
| 5 |
GSK
GSK
|
+$2.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$3.98M |
| 2 |
Equifax
EFX
|
+$3.93M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$3.49M |
| 4 |
3M
MMM
|
+$1.76M |
| 5 |
Otis Worldwide
OTIS
|
+$1.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.54% |
| 2 | Financials | 17.8% |
| 3 | Consumer Staples | 15.02% |
| 4 | Communication Services | 13.52% |
| 5 | Technology | 13.4% |
Similar funds
Arlington Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Arlington Partners held 68 positions worth $271M, up 6.4% from $255M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Arlington Partners deployed $11.5M of net new capital in Q2 2025, opening 10 new positions and adding to 25 existing holdings. Its largest new stake was UnitedHealth: 7,144 shares worth $2.23M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Staples.
On the sell side, the largest reduction was Vanguard Dividend Appreciation ETF, an estimated $3.49M trimmed.
- Arlington Partners's largest Q2 2025 buy was UnitedHealth: 7,144 shares worth $2.23M.
- Arlington Partners added most to Palmer Square Capital BDC in Q2 2025, an estimated $1.73M increase.
- Arlington Partners's biggest Q2 2025 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $3.49M.
- Arlington Partners fully exited Booking.com in Q2 2025, selling an estimated $3.98M.
- Arlington Partners's ten largest holdings make up 24% of its $271M portfolio in Q2 2025.
- Arlington Partners opened 10 new positions and closed 2 in Q2 2025.
- Arlington Partners's portfolio value rose 6.4% quarter-over-quarter to $271M.
Based on Arlington Partners's 13F filing for Q2 2025, filed 14 Jul 2025.